ArticleFrontiers in oncology2021

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer.

Lixia Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.